(Q35167908)

6 August 2017

1 reference

title

Implications of protein flexibility for drug discovery (English)

1 reference

6 August 2017

1 reference

Simon J Teague

1

1 reference

6 August 2017

1 July 2003

1 reference

Nature Reviews Drug Discovery

6 August 2017

1 reference

6 August 2017

2

1 reference

6 August 2017

527-541

1 reference

6 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd1129

6 August 2017

0 references

cites work

Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles.

1 reference

Manipulation of ligand binding affinity by exploitation of conformational coupling

31 March 2020

1 reference

Making a network of hydrophobic clusters

31 March 2020

1 reference

Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?

31 March 2020

1 reference

Ligand-induced distortion of an active site in thymidylate synthase upon binding anticancer drug 1843U89

31 March 2020

1 reference

Enzymology. A moving story

31 March 2020

1 reference

Enzyme dynamics during catalysis

31 March 2020

1 reference

Conformational switching in an aspartic proteinase

31 March 2020

1 reference

The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor

31 March 2020

1 reference

Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity.

31 March 2020

1 reference

Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations

31 March 2020

1 reference

A relationship between protein stability and protein function

31 March 2020

1 reference

Structural mechanisms for domain movements in proteins

31 March 2020

1 reference

Hydrogen Bonding, Hydrophobic Interactions, and Failure of the Rigid Receptor Hypothesis

31 March 2020

1 reference

Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs

31 March 2020

1 reference

Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors

31 March 2020

1 reference

Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma

31 March 2020

1 reference

Three-dimensional structures ofDrosophila melanogasteracetylcholinesterase and of its complexes with two potent inhibitors

31 March 2020

1 reference

Increased protein backbone conformational entropy upon hydrophobic ligand binding

31 March 2020

1 reference

A succession of substrate induced conformational changes ensures the amino acid specificity of Thermus thermophilus prolyl-tRNA synthetase: comparison with histidyl-tRNA synthetase

31 March 2020

1 reference

The application of thermodynamic methods in drug design

31 March 2020

1 reference

Side-chain flexibility in proteins upon ligand binding.

31 March 2020

1 reference

High resolution structures of HIV-1 RT from four RT-inhibitor complexes

31 March 2020

1 reference

Rational design of potent human transthyretin amyloid disease inhibitors

31 March 2020

1 reference

Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1

31 March 2020

1 reference

Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors

31 March 2020

1 reference

A new allosteric site in glycogen phosphorylase b as a target for drug interactions

31 March 2020

1 reference

The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor

31 March 2020

1 reference

Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography

31 March 2020

1 reference

Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats

31 March 2020

1 reference

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site

31 March 2020

1 reference

Mechanism of inhibition of cholinesterases by huperzine A

31 March 2020

1 reference

Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir

31 March 2020

1 reference

Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase1,21Escherichia coli thymidylate synthase numbering is used unless otherwise noted.2PDB coordinates have been deposited with the RCSB wi

31 March 2020

1 reference

Conformational dynamics along an enzymatic reaction pathway: thymidylate synthase, "the movie".

31 March 2020

1 reference

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B

31 March 2020

1 reference

Crystal structures of cytochrome P-450CAM complexed with camphane, thiocamphor, and adamantane: factors controlling P-450 substrate hydroxylation

31 March 2020

1 reference

The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity

31 March 2020

1 reference

Structural mechanisms of QacR induction and multidrug recognition

31 March 2020

1 reference

Building blocks, hinge-bending motions and protein topology.

31 March 2020

1 reference

Binding of small molecules to an adaptive protein-protein interface

31 March 2020

1 reference

Crystal structure of cytochrome P450 14 -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors

31 March 2020

1 reference

Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding

31 March 2020

1 reference

Domain flexibility in retroviral proteases: structural implications for drug resistant mutations

31 March 2020

1 reference

A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance

31 March 2020

1 reference

Conformational change of elongation factor Tu (EF-Tu) induced by antibiotic binding. Crystal structure of the complex between EF-Tu.GDP and aurodox

31 March 2020

1 reference

Deciphering common failures in molecular docking of ligand-protein complexes.

31 March 2020

1 reference

Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity

31 March 2020

1 reference

The sensitivity of the results of molecular docking to induced fit effects: application to thrombin, thermolysin and neuraminidase

31 March 2020

1 reference

Protein flexibility and drug design: how to hit a moving target.

31 March 2020

1 reference

Complexity and simplicity of ligand-macromolecule interactions: the energy landscape perspective

31 March 2020

1 reference

Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A

31 March 2020

1 reference

Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat

31 March 2020

1 reference

A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil

31 March 2020

1 reference

Active site plasticity in D-amino acid oxidase: a crystallographic analysis

31 March 2020

1 reference

The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates

31 March 2020

1 reference

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

31 March 2020

1 reference

Crystal structures of cystathionine gamma-synthase inhibitor complexes rationalize the increased affinity of a novel inhibitor

31 March 2020

1 reference

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

31 March 2020

1 reference

Molecular basis of agonism and antagonism in the oestrogen receptor

31 March 2020

1 reference

Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors

31 March 2020

1 reference

Human liver glycogen phosphorylase inhibitors bind at a new allosteric site

31 March 2020

1 reference

Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors

31 March 2020

1 reference

Molecular recognition of cyclic urea HIV-1 protease inhibitors

31 March 2020

1 reference

Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere

31 March 2020

1 reference

Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative design.

31 March 2020

1 reference

Structural mechanism for statin inhibition of HMG-CoA reductase

31 March 2020

1 reference

NMR characterization of the metallo-beta-lactamase from Bacteroides fragilis and its interaction with a tight-binding inhibitor: role of an active-site loop

31 March 2020

1 reference

Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors

31 March 2020

1 reference

Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor

31 March 2020

1 reference

The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition

31 March 2020

1 reference

Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism

31 March 2020

1 reference

Structure-Based Development of Anticancer Drugs

31 March 2020

1 reference

Structural basis of inhibitor selectivity in MAP kinases

31 March 2020

1 reference

The catalytic mechanism of cytochrome P450 BM3 involves a 6 Å movement of the bound substrate on reduction

31 March 2020

1 reference

Inhibitor-induced conformational change in cytochrome P-450CAM

31 March 2020

1 reference

Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam

31 March 2020

1 reference

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2

31 March 2020

1 reference

The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor

31 March 2020

1 reference

The crystal structures of human α-thrombin complexed with active site-directed diamino benzo[b] thiophene derivatives: A binding mode for a structurally novel class of inhibitors

31 March 2020

1 reference

Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site

31 March 2020

1 reference

Structure-based design of inhibitors specific for bacterial thymidylate synthase

31 March 2020

1 reference

Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence

31 March 2020

1 reference

The morph server: a standardized system for analyzing and visualizing macromolecular motions in a database framework

31 March 2020

1 reference

MolMovDB: analysis and visualization of conformational change and structural flexibility

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD1129

1 reference

PubMed ID

12838268

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12838268